PALLAS laser study for skin conditions
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new laser (PALLAS) that delivers targeted UVB light to treat skin conditions like psoriasis or eczema. It may help if your doctor thinks your skin problem could improve with UVB therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You must have a skin condition that the study doctor believes will respond to UVB light treatment
- You must be willing to sign a consent form
- You cannot be pregnant
- You cannot have epilepsy, fever, or an infectious disease
- You cannot be in another clinical trial or have been in one in the past month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a special light to see psoriasis tissue more clearly helps doctors remove it more precisely with a laser. It may lead to better treatment results for people with psoriasis.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This study tests whether combining hyperbaric oxygen (breathing pure oxygen in a special chamber) with narrowband UVB light therapy can improve vitiligo, a condition that causes white patches on the skin. The treatment aims to restore skin color by helping skin cells produce pigment.
This study uses a special UV light to look at your scalp in a new way. It may help doctors better understand and monitor alopecia areata (a condition that causes patchy hair loss). Participation involves only imaging, no drugs or invasive procedures.
This study tests whether narrowband ultraviolet B (UVB) light given three times a week for 12 weeks improves moderate-to-severe plaque psoriasis. It is an “open-label” pilot, meaning everyone gets the UVB treatment and researchers track how your skin responds.
This study looks at the health records of people with certain inflammatory skin diseases (such as psoriasis or eczema) in Italy to understand who gets them and what treatments they receive. By joining, you help doctors learn more about how these conditions are managed in real life.
Hear when a new Vitiligo Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.